Skip to content

Evaluation of Efficacy and Gynecological Acceptability of a Product for Health Care

Evaluation of Gynecological Acceptability of Product for Health Care with Perceived Effectiveness of Hydration and Maintenance of Vaginal pH

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
REBEC
Registry ID
RBR-422ssn
Enrollment
Unknown
Registered
2018-10-25
Start date
2018-11-16
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers with symptoms of vaginal dryness

Interventions

33 female participants, 40 to 70 years of age, healthy with complaints of vaginal dryness. The participants will be submitted to gynecological evaluation with gynecological examination and measurement
Device

Sponsors

Medcin Instituto da Pele Ltda
Lead Sponsor
Marjan Indústria e Comércio Ltda
Collaborator

Eligibility

Sex/Gender
Female
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 33 female participants; aged between 40 and 70 years; with vaginal dryness, presenting normal vaginal mucosa and who want to participate in the research

Exclusion criteria

Exclusion criteria: Gestation or risk of gestation / lactation; Use of anti-inflammatory / immunosuppressive / antihistamine drugs up to 3 weeks prior to screening; active cutaneous conditions; Use of other products in the genital area; Participants who use or intend to use intravaginal or systemic anti-infectives or systemic antifungal therapy during the study; Atopic or allergic history of intravaginal products; Immunosuppression by drugs or active diseases; endocrine disorders; Relevant clinical history or current evidence of alcohol or other drug abuse; Known history or suspected intolerance to products of the same category; Intense sun exposure up to 15 days before evaluation; Dermatological and / or gynecological treatments up to 4 weeks prior to screening;

Design outcomes

Primary

MeasureTime frame
To verify the safety of the investigational product, under normal conditions of use, through gynecological evaluations

Secondary

MeasureTime frame
To evaluate the perceived efficacy of the research product through a subjective questionnaire and pH measurements

Countries

Brazil

Contacts

Public ContactFlávia Addor

Medcin Instituto da Pele Ltda

flavia@medcinonline.com.br551136835366

Outcome results

None listed

Source: REBEC (via WHO ICTRP)